Wednesday, August 16, 2017 10:03:35 AM
1. All paid promotions are suspect in my opinion. Have you ever seen one that wasn't positive?
2. When this piece was written there were 30mm shares outstanding, not 1 billion.
3. Much of the value that they placed on the stock was predicated on OvaDX approval - OvaDX is no where near FDA submission. Technically Arrayit doesn't even own the IP anymore - Avant does.
4. There is a lot that COULD happen but I don't see the company doubling or tripling sales any time soon (basing this on an expected $6-$10mm revenue figure for 2016/2017). By the company's own admission, their growth mirrors Illumina's which was in the 10% range.
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM